http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5608086-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-72
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-72
filingDate 1995-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71e245523574425c1c80d19d220d9208
publicationDate 1997-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5608086-A
titleOfInvention Process for the preparation of intermediates for the synthesis of glucose-6-phosphatase inhibitors, and novel intermediates
abstract Cyclohexane derivatives of the formula I ##STR1## in which the radicals are as defined in the description, and processes for the preparation of these compounds, are described. Also described are novel intermediates for the preparation of the compounds of the formula I.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007173476-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006030735-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7186825-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7453011-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003195377-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004133013-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6982351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7312244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004235962-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007161692-A1
priorityDate 1994-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2105709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0587088-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128924060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128888880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128778904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234316560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19971769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234029887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67708718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127981362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5585

Total number of triples: 47.